Acupuncture for Pain Control After Elective Caesarean Section (ACUSEC)
8. januar 2021 opdateret af: University Medicine Greifswald
Acupuncture vs. Placebo Acupuncture and vs. Standard Therapy for Pain Control After Elective Caesarean Section - a Randomized Controlled Trial
The study entitled "Acupuncture vs. placebo acupuncture and vs. standard therapy for pain control after elective caesarian section - a randomized controlled trial" aims to investigate whether acupuncture with indwelling fixed needles reduces pain and analgesic requirement as compared to placebo and standard therapy in patients after after elective caesarian section (CS) in the period from January 2015 to May 2016.
For that purpose 180 adult patients scheduled to elective elective CS in spinal anesthesia will be recruited according to eligibility criteria. 120 patients will be randomized either to verum or placebo acupuncture, 60 patients will be included in non-randomized "standard therapy" arm. The outcome measures are: postoperative analgesic requirement, pain intensity, incidence of side effects and physiological parameters.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
180
Fase
- Fase 2
- Fase 3
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
-
Greifswald, Tyskland, 17475
- Ernst Moritz Arndt University
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
19 år til 45 år (Voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Kvinde
Beskrivelse
Inclusion Criteria:
- Patients with an American Society of Anaesthesiologists physical status of I to III scheduled for elective caesarean section in spinal anaesthesia
- Surgery time does not exceed 60 minutes
- Patients without previous opioid and psychotropic medication
- Patients ranged 19-45 years old
- Patients who have given written informed consent
Exclusion Criteria:
- Recidivist alcoholics
- Local skin infection at the sites of acupuncture
- Age < 19 and > 45 years
- Switching to general anaesthesia in cases where spinal anaesthesia fails
- Surgery time more than 60 minutes
- Intraoperative complications (bleeding, required blood transfusion more than 6 units of packed cells, cardiovascular instability, required catecholamines except for short hypotension after induction of spinal anaesthesia )
- Patients who consumed opioid medication at least 6 months before surgery
- Patients who are unable to understand the consent form and fill in the study questionnaire
- History of psychiatric disease
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Tredobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Verum acupuncture
Each patient will receive 16 permanent indwelling acupuncture needles, embedded in adhesive tape, bilaterally in addition to standard postoperative analgesia
|
Standard therapy includes pharmacologic treatment of postoperative pain according to the standards of our University hospital
Andre navne:
Verum acupuncture will be performed using indwelling permanent acupuncture needles "New Pyonex" with 1,5 mm length, manufactured by Seirin Corp.
Japan
|
|
Placebo komparator: Placebo acupuncture
Each patient will receive 16 adhesive tapes mimicking the indwelling acupuncture needles bilaterally in addition to standard postoperative analgesia
|
Standard therapy includes pharmacologic treatment of postoperative pain according to the standards of our University hospital
Andre navne:
Placebo acupuncture will be performed using the placebo "New Pyonex" adhesive tapes, mimicking the needles, manufactured by Seirin Corp.
Japan
Andre navne:
|
|
Aktiv komparator: Standard therapy
Each patient will receive just standard postoperative analgesia
|
Standard therapy includes pharmacologic treatment of postoperative pain according to the standards of our University hospital
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Pain intensity as measured by Numeric Rating Scale 1-10
Tidsramme: 4:00 P.M. on the 1st postoperative day
|
4:00 P.M. on the 1st postoperative day
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Total requirement of postoperative analgesics
Tidsramme: 4:00 P.M. on the 2nd postoperative day
|
4:00 P.M. on the 2nd postoperative day
|
|
Incidence of complications and adverse effects
Tidsramme: 4:00 P.M. on the 2nd postoperative day
|
4:00 P.M. on the 2nd postoperative day
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Studieleder: Taras I Usichenko, MD, PhD, University Medicine of Greifswald
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Generelle publikationer
- Zimpel SA, Torloni MR, Porfirio GJ, Flumignan RL, da Silva EM. Complementary and alternative therapies for post-caesarean pain. Cochrane Database Syst Rev. 2020 Sep 1;9(9):CD011216. doi: 10.1002/14651858.CD011216.pub2.
- Usichenko TI. Acupuncture as part of multimodal analgesia after caesarean section. Acupunct Med. 2014 Jun;32(3):297-8. doi: 10.1136/acupmed-2014-010584. Epub 2014 May 7. No abstract available.
- Usichenko TI, Henkel BJ, Klausenitz C, Hesse T, Pierdant G, Cummings M, Hahnenkamp K. Effectiveness of Acupuncture for Pain Control After Cesarean Delivery: A Randomized Clinical Trial. JAMA Netw Open. 2022 Feb 1;5(2):e220517. doi: 10.1001/jamanetworkopen.2022.0517. Erratum In: JAMA Netw Open. 2022 Apr 1;5(4):e229622.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
13. januar 2015
Primær færdiggørelse (Faktiske)
27. juni 2018
Studieafslutning (Faktiske)
27. juni 2018
Datoer for studieregistrering
Først indsendt
9. februar 2015
Først indsendt, der opfyldte QC-kriterier
13. februar 2015
Først opslået (Skøn)
16. februar 2015
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
11. januar 2021
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
8. januar 2021
Sidst verificeret
1. januar 2021
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- AC SC BB 04/15
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .